Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Lower NAD+ levels are also associated with repair enzymes like PARP1 and sirtuins becoming less effective, allowing DNA damage and cellular stress to accumulate[1]
WO2014052766A1 - Hepatocyte growth factor mimics as therapeutic agents - Google Patents Hepatocyte growth factor mimics as therapeutic agents Download PDF Info Publication number WO2014052766A1 WO2014052766A1 PCT/US2013/062199 US2013062199W WO2014052766A1 WO 2014052766 A1 WO2014052766 A1 WO 2014052766A1 US 2013062199 W US2013062199 W US 2013062199W WO 2014052766 A1 WO2014052766 A1 WO 2014052766A1 Authority WO WIPO (PCT) Prior art keywords hgf dihexa group mimics nle Prior art date Legal status (The legal status is an assumption and is not a legal conclusion
(United States of America: John Wiley & Sons Ltd) pp.169187
Figure S3
US$ 25.07
:max_bytes(150000):strip_icc()/nasal-spray-GettyImages-1307364119-342cadbe116d4cc7b773e3869d833779.jpg)
US$ 20.75
US$ 21.05
US$ 21.81
US$ 20.26
US$ 27.60
